Drug Delivery System Market Size Report & Global Outlook 2027
[Research Report] The drug delivery system market was valued at US$ 1,243,111.7 million in 2018 and it is projected to reach US$ 2,302,227.2 million in 2027; it is expected to grow at a CAGR of 7.2% from 2019 to 2027.
Analyst Perspective:
The global drug delivery system market is significantly driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer, coupled with technological advancements in the manufacturing and development of innovative devices for pharmaceutical drug delivery. Diabetes is a prominent reason behind kidney failure, heart attacks, blindness, and stroke. Therefore, the rapidly growing prevalence of various chronic diseases across the globe is significantly boosting the demand for various innovative drugs for treatment, which augments the drug delivery system market growth.
The rapidly growing biopharmaceutical industry and the development of various new and innovative drugs are significantly driving the growth of the drug delivery system market. The growing investments by the top pharmaceutical manufacturers in the research and development of new drugs to treat incurable diseases are augmenting the need for various pharmaceutical drug delivery solutions around the globe. Furthermore, several top market players in the drug delivery system market and the key developmental strategies such as product launches, mergers & acquisitions, and partnerships they adopted significantly drive the market growth. Therefore, the rising penetration of drug and gene delivery device companies across the globe is boosting the market growth.
Market Overview:
A drug delivery system (DDS) is a formulation or a device that enables the introduction of a therapeutic substance into the body that improves its efficacy and safety by controlling the rate, time, and place of release of drugs into the body. Drug delivery systems have substantially evolved over the last six decades. In the last 12 years majorly, there have been huge advancements in drug delivery technology. For instance, advanced medication delivery systems, such as transdermal patches, are able to deliver a drug more selectively to a specific site, which frequently leads to easier, more accurate, and less dosing overall. There are other drug delivery systems used in both medical and home care settings that were developed because of various patient needs, and researchers continue to develop new methods.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Drug Delivery Systems Market: Strategic Insights
Market Size Value in US$ 1,243,111.7 Million in 2018 Market Size Value by US$ 2,302,227.2 Million by 2027 Growth rate CAGR of 7.2% from 2019-2027 Forecast Period 2019-2027 Base Year 2019
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Drug Delivery Systems Market: Strategic Insights
| Market Size Value in | US$ 1,243,111.7 Million in 2018 |
| Market Size Value by | US$ 2,302,227.2 Million by 2027 |
| Growth rate | CAGR of 7.2% from 2019-2027 |
| Forecast Period | 2019-2027 |
| Base Year | 2019 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Driver:
Rising Incidence of Chronic Diseases to Drive Drug Delivery System Market Growth
As drug delivery devices help deliver the drugs, which are beneficial for the targeted population to recover faster, there has been a growing adoption of and inclination toward advanced drug delivery devices. Moreover, a rising number of cancers, respiratory disease, and diabetic patients worldwide may promote the adoption of drug delivery system and drive the overall market. According to the World Health Organization (WHO), cancer is the biggest cause of death worldwide, with approximately 10 million deaths in 2020. Overall, the global burden of cancer incidence and death is quickly increasing. As per the CDC, in 2020, 1,603,844 new cancer cases were reported, and 602,347 people died of cancer in the US. Breast, colorectal, lung, cervical, and thyroid cancers are common among women. In contrast, lung and prostate cancer is the most common among men, accounting for nearly one-third of all male cancers. This growing burden of cancer increases the adoption of drug delivery devices, contributing significantly to the drug delivery system market's growth.
Segmental Analysis:
Based on application, the drug delivery system market is categorized into homecare settings, hospitals & clinics and others. In 2018, hospitals and clinics segment held the major share in the drug delivery system market. The homecare settings segment is expected to register a significant growth in the drug delivery system market during the forecast period. The hospital is a complex organization and an institute that provides health to people through complicated but specialized scientific equipment and team of trained staff educated in the problems of modern medical science. They are all coordinated together for the common goal of restoring and maintain good health. Hospitals serves a significant role by providing extensive range of medical services to the patient population suffering from wide variety of diseases. This increased the adoption of drug delivery systems in hospitals and clinics. For instance, according to Centers for Disease Control and Prevention (CDC), in 2014, a total number of 7.2 million hospital discharges were reported with diabetes in the US among adult population aged 18 years or older. This is expected to increase the treatment process for controlling and treating chronic conditions, which in turn is expected to increase the usage of drug delivery systems in the hospitals.
Regional Analysis:
In North America, US is the largest market for drug delivery system market. The growth of this market is primarily driven by increasing prevalence of chronic diseases like diabetes, asthma and others, growing number of product launches by key players; and increasing use of drug delivery devices for disease management. According to the National Center for Health Statistics, in 2023, 1.9 million new cancer cases and 609,820 cancer deaths are projected to occur in the US, and cancer cases are further expected to increase in the country, which is expected to increase the demand for the drug delivery systems for various therapeutics as demand for cancer treatment is quite high in the region owing to the high mortality rate associated with the disease, which is expected to boost growth in the drug delivery system market.
The launch of new products in the country will also help drive drug delivery system market growth. For instance, in February 2022, the US FDA approved the generic Apokyn (apomorphine hydrochloride injection) drug cartridges to treat hypomobility and other episodes associated with advanced Parkinson’s disease. In January 2021, Novartis AG invested in Credence MedSystems to support the development and scale-up of its drug delivery systems. This initiative facilitates Novartis AG's use of Credence technology in its injectable medicines. Similarly, in November 2020, Croda International PLC entered into an agreement with Pfizer Inc. to supply innovative drug delivery systems for Pfizer’s COVID-19 vaccine candidate.
Furthermore, in March 2022, Corium received US FDA approval for Adlarity to treat patients with mild, moderate, or severe dementia associated with Alzheimer’s. The launch of transdermal patches in the country is expected to boost the studied market during the study period. Moreover, strategic initiatives by market players, such as partnerships and collaborations for increasing the production of drug delivery devices, would lead to lucrative market growth. For instance, in May 2020, the Department of Defense and the United States Department of Health and Human Services awarded a contract worth USD 138 million to ApiJect Systems America for "Project Jumpstart" and "RAPID USA," which will work together to expand the United States' production capability of medical-grade injection devices.
Key Player Analysis:
The drug delivery system market analysis consists of players, such as BD, 3M, Novo Nordisk A/S, BD, Novo Nordisk A/S, 3M, Boston Scientific Corporation, Bausch Health Companies Inc., Baxter International, Inc., Boehringer Ingelheim, Novartis AG, GlaxoSmithKline plc. and Johnson & Johnson Services, Inc. Among the players in the drug delivery system market, 3M and BD are the top two players owing to the diversified product portfolio offered.
Drug Delivery System Market Report Scope
Recent Developments:
Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the drug delivery system market. A few recent key market developments are listed below:
- In June 2022, Gufic Biosciences Ltd launched a new drug delivery system, Dual Chamber Bags, at affordable prices for the first time in India. One of the most important USPs of these ready-to-use Dual Chamber Bags by Gufic is that they prevent contamination and protects the potency and efficacy of the drug. These bags also offer ease of handling at the time of reconstitution and also help in avoiding the dilution errors since the drug is present with the exact required quantity of the diluent to be used.
- In February 2022, Takeda received US FDA approval for TAKHZYRO (lanadelumab-flyo) injection in a single-dose prefilled syringe (PFS), which is used to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older. The PFS is ready to use and requires fewer preparation steps than the current TAKHZYRO vial injection, while also reducing supplies and waste.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Route of Administration, Distribution Channel, Application and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 market segmentation
1.3.1 Global Drug delivery systems market – By
1.3.2 Global Drug delivery systems market – By Application
1.3.3 Global Drug delivery systems market – By Distribution Channel
1.3.4 Global Drug delivery systems market – By Geography
2. Global Drug delivery systems market – Key takeaways
3. research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Drug delivery systems– market landscape
4.1 overview
4.2 pest analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 South & Central America – PEST Analysis
5. drug delivery systems market – Key Market Dyanamics
5.1 Key Market Drivers
5.1.1 Rising Incidence of Chronic Diseases
5.1.2 Growing Demand for Non Invasive Drug Delivery Devices
5.1.3 Increasing R&D Expenditures in Pharmaceutical And Medical Device Companies
5.2 Key Market Restraints
5.2.1 High Cost Involved In Development Of Drug Delivery Devices
5.2.2 Product Recalls
5.3 Key Market Opportunities
5.3.1 Increasing Patient Compliance
5.4 Future Trends
5.4.1 Growing New Innovations In Drug Delivery Technology
5.5 Impact analysis
6. drug delivery systems market – Global Analysis
6.1 global drug delivery systems market Revenue Forecasts and Analysis
6.2 global Drug delivery systems market, By Geography - Forecasts and Analysis
6.3 PERFORMANCE OF Prominent PLAYERS
6.3.1 BD
6.3.2 3M
6.3.3 GlaxoSmithKline plc.
6.3.4 Novartis AG
7. drug Delivery systems Market – global Regulatory Scenario
7.1 north america
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.3 ASia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.4 middle east & africa
7.4.1 Saudi Arabia
7.4.2 South Africa
7.5 South & Central America
7.5.1 Brazil
8. drug delivery systems market Analysis and forecasts to 2027 – route of administration
8.1 Overview
8.2 Route of administration market Revenue and Forecasts Analysis (US$ Mn)
8.3 oral drug delivery Market
8.3.1 Overview
8.3.2 Oral Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.3.3 Solid Oral Drugs Market
8.3.3.1 Overview
8.3.3.2 Solid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
8.3.3.3 SOLID ORAL DRUGS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.3.4 Liquid Oral Drugs Market
8.3.4.1 Overview
8.3.4.2 Liquid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
8.3.4.3 Liquid Oral Drugs MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.3.5 Semi-solid Oral Drugs Market
8.3.5.1 Overview
8.3.5.2 Semi-Solid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)
8.3.5.3 SEMI-SOLID ORAL DRUGS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4 transmucosal drug delivery Market
8.4.1 Overview
8.4.2 Transmucosal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
Source: The Insight Partners Analysis, Primary Interviews, Secondary Sources
8.4.3 Pulmonary Drug Delivery Market
8.4.3.1 Overview
8.4.3.2 Pulmonary Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.4.3.3 PULMONARY DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.3.4 In-metered Dose Inhalers Market
8.4.3.4.1 Overview
8.4.3.4.2 In-metered Dose Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
8.4.3.4.3 IN-METERED DOSE INHALERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.3.5 Dry Powder Inhalers Market
8.4.3.5.1 Overview
8.4.3.5.2 Dry Powder Inhalers Market Revenue and Forecast to 2027 (US$ Mn)
8.4.3.5.3 DRY POWDER INHALERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.3.6 Nebulizers Market
8.4.3.6.1 Overview
8.4.3.6.2 Nebulizers Market Revenue and Forecast to 2027 (US$ Mn)
8.4.3.6.3 NEBULIZERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.4 Nasal Drug Delivery Market
8.4.4.1 Overview
8.4.4.2 Nasal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.4.4.3 NASAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.4.4 Nasal Spray Market
8.4.4.4.1 Overview
8.4.4.4.2 Nasal Spray Market Revenue and Forecast to 2027 (US$ Mn)
8.4.4.4.3 NASAL SPRAY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.4.5 Nasal Drops Market
8.4.4.5.1 Overview
8.4.4.5.2 Nasal Drops Market Revenue and Forecast to 2027 (US$ Mn)
8.4.4.5.3 NASAL SPRAY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.4.6 Nasal Gel Market
8.4.4.6.1 Overview
8.4.4.6.2 Nasal Gel Market Revenue and Forecast to 2027 (US$ Mn)
8.4.4.6.3 NASAL GEL MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
Source: The Insight Partners Analysis, Primary Interviews, Secondary Sources
8.4.5 Buccal Drug Delivery Market
8.4.5.1 Overview
8.4.5.2 Buccal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.4.5.3 BUCCAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.6 Sublingual Drug Delivery Market
8.4.6.1 Overview
8.4.6.2 Sublingual Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.4.6.3 SUBLINGUAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.7 Rectal Transmucosal Drug Delivery Market
8.4.7.1 Overview
8.4.7.2 Rectal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.4.7.3 RECTAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.4.8 Vaginal Transmucosal Drug Delivery Market
8.4.8.1 Overview
8.4.8.2 Vaginal Transmucosal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.4.8.3 VAGINAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.5 Topical drug delivery Market
8.5.1 Overview
8.5.2 Topical Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
8.5.3 Semi-solid Topical Drug Delivery Formulations Market
8.5.3.1 Overview
8.5.3.2 Semi-solid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
8.5.3.3 SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.5.4 Liquid Topical Drug Delivery Formulations Market
8.5.4.1 Overview
8.5.4.2 Liquid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
8.5.4.3 LIQUID TOPICAL DRUG DELIVERY FORMULATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.5.5 Solid Topical Drug Delivery Formulations Market
8.5.5.1 Overview
8.5.5.2 Solid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)
8.5.5.3 SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.5.6 Transdermal Patches Market
8.5.6.1 Overview
8.5.6.2 Transdermal Patches Market Revenue and Forecast to 2027 (US$ Mn)
8.5.6.3 TRANSDERMAL PATCHES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.5.7 Transdermal Gels Market
8.5.7.1 Overview
8.5.7.2 Transdermal Gels Market Revenue and Forecast to 2027 (US$ Mn)
8.5.7.3 TRANSDERMAL GELS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.5.8 Others Market
8.5.8.1 Overview
8.5.8.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
8.5.8.3 OTHERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.6 injectable drug delivery Market
8.6.1 Overview
8.6.2 Injectable Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
Source: The Insight Partners Analysis, Primary Interviews, Secondary Sources
8.6.3 Conventional Injection Devices Market
8.6.3.1 Overview
8.6.3.2 Conventional Injection Devices Market Revenue and Forecast to 2027 (US$ Mn)
8.6.3.3 CONVENTIONAL INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.6.4 Self-Injection Devices Market
8.6.4.1 Overview
8.6.4.2 SELF-INJECTION Devices Market Revenue and Forecast to 2027 (US$ Mn)
8.6.4.3 SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.6.4.4 Needle Free Injectors Market
8.6.4.4.1 Overview
8.6.4.4.2 Needle Free Injectors Market Revenue and Forecast to 2027 (US$ Mn)
8.6.4.4.3 NEEDLE FREE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.6.4.5 Pen injectors Market
8.6.4.5.1 Overview
8.6.4.5.2 Pen injectors Market Revenue and Forecast to 2027 (US$ Mn)
8.6.4.5.3 PEN INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.6.4.6 Wearable Injectors Market
8.6.4.6.1 Overview
8.6.4.6.2 Wearable Injectors Market Revenue and Forecast to 2027 (US$ Mn)
8.6.4.6.3 WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.7 Implantable drug delivery Market
8.7.1 Overview
8.7.2 Implantable drug delivery Market Revenue and Forecast to 2027 (US$ Mn)
Source: The Insight Partners Analysis, Primary Interviews, Secondary Sources
8.7.3 Active Implantable Market
8.7.3.1 Overview
8.7.3.2 Active Implantable Market Revenue and Forecast to 2027 (US$ Mn)
8.7.3.3 ACTIVE IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.7.4 Passive Implantable Market
8.7.4.1 Overview
8.7.4.2 Passive Implantable Market Revenue and Forecast to 2027 (US$ Mn)
8.7.4.3 Passive Implantable MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.8 ocular drug delivery Market
8.8.1 Overview
8.8.2 Ocular Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)
Source: The Insight Partners Analysis, Primary Interviews, Secondary Sources
8.8.3 Eye Drops and Sprays Market
8.8.3.1 Overview
8.8.3.2 Eye Drops and Sprays Market Revenue and Forecast to 2027 (US$ Mn)
8.8.3.3 Eye Drops And Spray MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.8.4 Gels & Ointments Market
8.8.4.1 Overview
8.8.4.2 Gels & Ointments Market Revenue and Forecast to 2027 (US$ Mn)
8.8.4.3 Gels & Ointments MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.8.5 Ocular Inserts Market
8.8.5.1 Overview
8.8.5.2 Ocular Inserts Market Revenue and Forecast to 2027 (US$ Mn)
8.8.5.3 Occular Inserts MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
8.8.6 Drug Coated Contact Lens Market
8.8.6.1 Overview
8.8.6.2 Drug Coated Contact Lens Market Revenue and Forecast to 2027 (US$ Mn)
8.8.6.3 Drug Coated Contact Lens MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
9. global drug delivery systems Market analysis– by distribution channel
9.1 overview
9.2 global drug delivery systems MARKET, by distribution channel 2018 & 2027 (%)
9.3 hospital pharmacies market
9.3.1 Overview
9.3.2 Global Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 retail pharmacies market
9.4.1 Overview
9.4.2 Global Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 online pharmacies market
9.5.1 Overview
9.5.2 Global Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10. global drug delivery systems Market analysis– by Application
10.1 overview
10.2 global drug delivery systems MARKET, by applicaton 2018 & 2027 (%)
10.3 homecare Settings market
10.3.1 Overview
10.3.2 Global Homecare Settings Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 hospitals & clinics Market
10.4.1 Overview
10.4.2 Global Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 others Market
10.5.1 Overview
10.5.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
11. Drug delivery systems market REVENUE AND FORECASTS TO 2027 – GeographicAL ANALYSIS
11.1 north america drug delivery market
11.1.1 Overview
11.1.2 North America Drug Delivery Market Revenue And Forecasts to 2027 (US$ Mn)
11.1.3 North America Drug Delivery Market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
11.1.3.1 North America Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.3.2 North America Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.3.3 North America Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.3.4 North America Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.3.4.1 North America Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.3.5 North America Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.3.6 North America Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.3.7 North America Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.3.8 North America Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.4 North America Drug delivery market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.1.5 North America Drug delivery market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.1.6 North America Drug delivery Market Revenue And Forecasts to 2027, By Country (%)
11.1.7 US Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8 US Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.1 US Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.8.1.1 US Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.8.1.2 US oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.8.1.3 US Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.8.1.4 US Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.8.1.4.1 US Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.8.1.5 US Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.8.1.6 US Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.8.1.7 US Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.8.1.8 US Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.8.2 US Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.1.8.3 US Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.1.9 Canada Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.1.10 Canada Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.1.10.1 Canada Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.10.1.1 Canada Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.10.1.2 Canada Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.10.1.3 Canada Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.10.1.4 Canada Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.10.1.5 Canada Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.10.1.6 Canada Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.10.1.7 Canada Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.10.1.8 Canada Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.10.1.9 Canada Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.10.2 Canada Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.1.10.3 Canada Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.1.11 Mexico Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.1.12 Mexico Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.1.12.1 Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.12.1.1 Mexico Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.12.1.2 Mexico Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.12.1.3 Mexico Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.12.1.4 Mexico Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.12.1.5 Mexico Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.12.1.6 Mexico Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.12.1.7 Mexico Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.12.1.8 Mexico Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.12.1.9 Mexico Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.1.12.2 Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.1.12.3 Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.2 Europe drug delivery systems market
11.2.1 Overview
11.2.2 Europe Drug delivery systems market revenue Overview, by Country (2017) (US$ Mn)
11.2.3 Europe Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.2.4 Europe Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.4.1 Europe Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.4.2 Europe oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.4.3 Europe Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.4.4 Europe Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.4.5 Europe Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.4.6 Europe Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.4.7 Europe Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.4.8 Europe Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.4.9 Europe Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.5 Europe Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.6 Europe Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.2.7 Europe Drug delivery systems market Revenue and Forecasts to 2027, By Country (%)
11.2.8 Germany Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9 Germany Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.1 Germany Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.9.1.1 Germany Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.9.1.2 Germany Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.9.1.3 Germany Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.9.1.4 Germany Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.9.1.4.1 Germany Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.9.1.5 Germany Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.9.1.6 Germany Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.9.1.7 Germany Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.9.1.8 Germany Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.9.2 Germany Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.9.3 Germany Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.2.10 France Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.2.11 France Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.2.11.1 France Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.11.1.1 France Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.11.1.2 France Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.11.1.3 France Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.11.1.4 France Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.11.1.5 France Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.11.1.6 France Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.11.1.7 France Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.11.1.8 France Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.11.1.9 France Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.11.2 France Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.11.3 France Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.2.12 UK Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.2.13 UK Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.2.13.1 UK Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.13.1.1 UK Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.13.1.2 UK Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.13.1.3 UK Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.13.1.4 UK Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.13.1.5 UK Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.13.1.6 UK Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.13.1.7 UK Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.13.1.8 UK Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.13.1.9 UK Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.2.13.2 UK Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.2.13.3 UK Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.3 ASIA Pacific DRUG DELIVERY SYSTEMS MARKET
11.3.1 Overview
11.3.2 Asia Pacific Drug delivery systems market Revenue And Forecasts to 2027 (US$ Mn)
11.3.3 Asia Pacific Drug delivery systems market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)
11.3.3.1 Asia Pacific Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.3.2 Asia Pacific Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.3.3 Asia Pacific Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.3.4 Asia Pacific Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.3.4.1 Asia Pacific Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.3.5 Asia Pacific Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.3.6 Asia Pacific Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.3.7 Asia Pacific Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.3.8 Asia Pacific Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.4 Asia Pacific Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.3.5 Asia Pacific Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.3.6 Asia Pacific Drug delivery systems market Revenue and Forecasts to 2027, By Country (%)
11.3.7 China Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.3.8 China Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.3.8.1 China Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.8.1.1 China Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.8.1.2 China Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.8.1.3 China Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.8.1.4 China Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.8.1.5 China Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.8.1.6 China Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.8.1.7 China Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.8.1.8 China Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.8.1.9 China Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.8.2 China Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.3.8.3 China Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Source: The Insight Partners
11.3.9 Japan Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.3.10 Japan Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.3.10.1 Japan Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.10.1.1 Japan Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.10.1.2 Japan Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.10.1.3 Japan Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.10.1.4 Japan Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.10.1.5 Japan Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.10.1.6 Japan Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.10.1.7 Japan Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.10.1.8 Japan Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.10.1.9 Japan Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.10.2 Japan Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.3.10.3 Japan Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.3.11 India Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.3.12 India Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.3.12.1 India Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.12.1.1 India Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.12.1.2 India Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.12.1.3 India Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.12.1.4 India Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.12.1.5 India Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.12.1.6 India Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.12.1.7 India Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.12.1.8 India Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.12.1.9 India Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.3.12.2 India Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.3.12.3 India Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.4 Middle East & Africa Drug delivery systems market
11.4.1 Middle East & Africa Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.4.2 Middle East & Africa Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.2.1 Middle East & Africa Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.2.2 Middle East & Africa oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.2.3 Middle East & Africa Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.2.4 Middle East & Africa Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.2.5 Middle East & Africa Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.2.6 Middle East & Africa Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.2.7 Middle East & Africa Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.2.8 Middle East & Africa Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.2.9 Middle East & Africa Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.3 Middle East & Africa Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.4.4 Middle East & Africa Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.4.5 Middle East & Africa Drug delivery systems market Revenue and Forecasts to 2027, By Country (%)
11.4.6 UAE Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.4.7 UAE Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.4.7.1 UAE Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.7.1.1 UAE Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.7.1.2 UAE Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.7.1.3 UAE Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.7.1.4 UAE Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.7.1.5 UAE Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.7.1.6 UAE Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.7.1.7 UAE Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.7.1.8 UAE Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.7.1.9 UAE Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.7.2 UAE Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.4.7.3 UAE Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.4.8 Saudi Arabia Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.4.9 Saudi Arabia Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.4.9.1 SAUDI ARABIA Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.9.1.1 SAUDI ARABIA Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.9.1.2 SAUDI ARABIA Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.9.1.3 SAUDI ARABIA Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.9.1.4 SAUDI ARABIA Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.9.1.5 SAUDI ARABIA Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.9.1.6 SAUDI ARABIA Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.9.1.7 SAUDI ARABIA Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.9.1.8 SAUDI ARABIA Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.9.1.9 SAUDI ARABIA Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.9.2 SAUDI ARABIA Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.4.9.3 SAUDI ARABIA Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.4.10 South Africa Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.4.11 South Africa Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.4.11.1 SOUTH AFRICA Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.11.1.1 SOUTH AFRICA Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.11.1.2 SOUTH AFRICA Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.11.1.3 SOUTH AFRICA Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.11.1.4 SOUTH AFRICA Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.11.1.5 SOUTH AFRICA Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.11.1.6 SOUTH AFRICA Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.11.1.7 SOUTH AFRICA Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.11.1.8 SOUTH AFRICA Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.11.1.9 SOUTH AFRICA Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.4.11.2 SOUTH AFRICA Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.4.11.3 SOUTH AFRICA Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.5 SOUTH AND CENTRAL AMERICA DRUG DELIVERY SYSTEMS MARKET
11.5.1 Overview
11.5.2 South and Central America Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.5.3 South and Central America Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.3.1 South and Central America Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.3.2 South and Central America oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.3.3 South and Central America Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.3.4 South and Central AmericaInjectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.3.5 South and Central America Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.3.6 South and Central America Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.3.7 South and Central America Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.3.8 South and Central America Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.3.9 South and Central America Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.4 South and Central America Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.5.5 South and Central America Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11.5.6 South and Central America Drug delivery systems market Share by Country, 2017 and 2027 (%)
11.5.7 Brazil Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.5.8 Brazil Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
11.5.8.1 Brazil Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.8.1.1 Brazil Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.8.1.2 Brazil Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.8.1.3 Brazil Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.8.1.4 Brazil Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.8.1.4.1 Brazil Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.8.1.5 Brazil Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.8.1.6 Brazil Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.8.1.7 Brazil Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.8.1.8 Brazil Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)
11.5.8.2 Brazil Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)
11.5.8.3 Brazil Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
12. drug delivery systems market – Industry Landscape
12.1 Overview
12.2 Comparative Company Analysis
12.3 Growth Strategies done by the companies in the Market, (%)
12.4 Organic Developments
12.4.1 Overview
12.5 Inorganic developments
12.5.1 Overview
13. Drug delivery systems market–Key company profiles
13.1 3M
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Financial Overview
13.1.4 Product Portfolio
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 BD
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Financial Overview
13.2.4 Product Portfolio
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Boston Scientific Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Financial Overview
13.3.4 Product Portfolio
13.3.5 Swot Analysis
13.3.6 Key Developments
13.4 novo nordisk a/s
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Financial Overview
13.4.4 Product Portfolio
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bausch Health Companies Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Financial Overview
13.5.4 Product Portfolio
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BAxter International, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Financial Overview
13.6.4 Product Portfolio
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Boehringer Ingelheim International GmbH
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product Portfolio
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Novartis AG
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Information
13.8.4 Product Portfolio
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 GlaxoSmithKline plc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Financial Overview
13.9.4 Product Portfolio
13.9.5 Swot Analysis
13.9.6 Key Developments
13.10 Johnson & Johnson Services, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Overview
13.10.4 Product Portfolio
13.10.5 Swot Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
list of tables
TABLE 1. R&D Investments by major pharmaceutical companies
TABLE 2. North America Drug delivery market Revenue And Forecasts to 2027, By route of administration (US$ Mn)
TABLE 3. North America Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 4. North America oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 5. North America Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 6. North America Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 7. North America Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 8. North America topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 9. North America nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 10. North America Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 11. North America Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 12. North America Drug delivery market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 13. North America Drug delivery market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 14. US Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 15. US Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 16. US oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 17. US Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 18. US Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 19. US Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 20. US topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 21. US nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 22. US Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 23. US Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 24. US Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 25. US Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 26. Canada Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 27. Canada Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 28. Canada oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 29. Canada Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 30. Canada Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 31. Canada Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 32. Canada topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 33. Canada nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 34. Canada Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 35. Canada Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 36. Canada Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 37. Canada Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 38. Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 39. Mexico Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 40. Mexico oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 41. Mexico Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 42. Mexico Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 43. Mexico Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 44. Mexico topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 45. Mexico nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 46. Mexico Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 47. Mexico Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 48. Mexico Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 49. Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 50. Europe Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 51. Europe Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 52. Europe oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 53. Europe Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 54. Europe Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 55. Europe Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 56. Europe topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 57. Europe nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 58. Europe Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 59. Europe Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 60. Europe Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 61. Europe Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 62. Germany Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 63. Germany Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 64. Germany oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 65. Germany Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 66. Germany Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 67. Germany Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 68. Germany topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 69. Germany nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 70. Germany Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 71. Germany Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 72. Germany Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 73. Germany Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 74. France Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 75. France Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 76. France oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 77. France Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 78. France Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 79. France Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 80. France topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 81. France nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 82. France Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 83. France Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 84. France Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 85. France Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 86. UK Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 87. UK Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 88. UK oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 89. UK Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 90. UK Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 91. UK Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 92. UK topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 93. UK nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 94. UK Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 95. UK Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 96. UK Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 97. UK Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 98. Asia Pacific Drug delivery systems market Revenue And Forecasts to 2027, By route of administration (US$ Mn)
TABLE 99. Asia Pacific Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 100. Asia Pacific oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 101. Asia Pacific Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 102. Asia Pacific Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 103. Asia Pacific Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 104. Asia Pacific topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 105. Asia Pacific nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 106. Asia Pacific Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 107. Asia Pacific Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 108. Asia Pacific Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 109. Asia Pacific Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 110. China Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 111. China Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 112. China oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 113. China Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 114. China Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 115. China Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 116. China topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 117. China nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 118. China Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 119. China Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 120. China Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 121. China Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 122. Japan Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 123. Japan Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 124. Japan oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 125. Japan Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 126. Japan Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 127. Japan Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 128. Japan topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 129. Japan nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 130. Japan Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 131. Japan Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 132. Japan Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 133. Japan Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 134. India Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 135. India Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 136. India oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 137. India Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 138. India Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 139. India Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 140. India topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 141. India nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 142. India Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 143. India Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 144. India Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 145. India Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 146. Middle East & Africa Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 147. Middle East & Africa Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 148. Middle East & Africa oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 149. Middle East & Africa Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 150. Middle East & Africa Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 151. Middle East & Africa Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 152. Middle East & Africa topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 153. Middle East & Africa nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 154. Middle East & Africa Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 155. Middle East & Africa Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 156. Middle East & Africa Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 157. Middle East & Africa Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 158. UAE Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 159. UAE Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 160. UAE oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 161. UAE Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 162. UAE Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 163. UAE Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 164. UAE topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 165. UAE nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 166. UAE Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 167. UAE Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 168. UAE Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 169. UAE Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 170. SAUDI ARABIA Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 171. SAUDI ARABIA Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 172. SAUDI ARABIA oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 173. SAUDI ARABIA Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 174. SAUDI ARABIA Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 175. SAUDI ARABIA Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 176. SAUDI ARABIA topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 177. SAUDI ARABIA nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 178. SAUDI ARABIA Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 179. SAUDI ARABIA Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 180. SAUDI ARABIA Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 181. SAUDI ARABIA Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 182. SOUTH AFRICA Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 183. SOUTH AFRICA Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 184. SOUTH AFRICA oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 185. SOUTH AFRICA Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 186. SOUTH AFRICA Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 187. SOUTH AFRICA Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 188. SOUTH AFRICA topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 189. SOUTH AFRICA nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 190. SOUTH AFRICA Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 191. SOUTH AFRICA Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 192. SOUTH AFRICA Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 193. SOUTH AFRICA Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 194. South and Central AmericaDrug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 195. South and Central AmericaTransmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 196. South and Central America oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 197. South and Central America Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 198. South and Central AmericaInjectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 199. South and Central AmericaSelf-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 200. South and Central Americatopical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 201. South and Central America nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 202. South and Central America Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 203. South and Central AmericaOcular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 204. South and Central AmericaDrug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 205. South and Central America Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 206. Brazil Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 207. Brazil Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 208. Brazil oral market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 209. Brazil Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 210. Brazil Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 211. Brazil Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 212. Brazil topical market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 213. Brazil nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 214. Brazil Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 215. Brazil Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 216. Brazil Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 217. Brazil Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 218. Organic Developments Done By Companies
TABLE 219. Inorganic developments done by Companies
TABLE 220. Glossary of Terms, Drug delivery systems market
list of figures
FIGURE 1. drug delivery systems market Segmentation
FIGURE 2. drug delivery systems Segmentation, by region
FIGURE 3. Asia PAcific Drug delivery systems market, Revenue (US$ Mn), 2018 & 2027
FIGURE 4. Global drug delivery systems market By Product, Market Share (%), 2018
FIGURE 5. Global Drug delivery systems market By application, Market Share (%), 2018
FIGURE 6. Global Drug delivery systems market By distribution channel, Market Share (%), 2018
FIGURE 7. North America PEST Analysis
FIGURE 8. Europe PEST Analysis
FIGURE 9. Asia Pacific PEST Analysis
FIGURE 10. Middle East & Africa PEST Analysis
FIGURE 11. South & Central America PEST Analysis
FIGURE 12. drug delivery systems market impact analysis of driver and restraints
FIGURE 13. global drug delivery systems market – Revenue Forecasts and Analysis –2018- 2027
FIGURE 14. global drug delivery systems market – by geography Forecasts and Analysis – 2018- 2027
FIGURE 15. Route of administration MARKET Analysis and Forecasts 2018 and 2027 (%)
FIGURE 16. Oral Drug Delivery Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 17. transmucosal Drug Delivery Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 18. topical Drug Delivery Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 19. injectable Drug Delivery Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 20. Implantable drug delivery Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 21. Ocular drug delivery Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 22. global drug delivery systems Market breakdown, by end user 2018 & 2027 (%)
FIGURE 23. Global HOSPITAL PHARMACIES Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 24. Global RETAIL PHARMACIES Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 25. Global online PHARMACIES Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 26. global drug delivery systems Market breakdown, by application 2018 & 2027 (%)
FIGURE 27. Global Homecare Settings Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 28. Global Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 29. Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 30. North America Drug delivery market revenue Overview, by Country (2018) (us $ mn)
FIGURE 31. North America Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 32. North America Drug delivery systems market Revenue And Forecasts to 2027, By Country (%)
FIGURE 33. US Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 34. Canada Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 35. Mexico Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 36. Europe Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 37. Europe Drug delivery systems market Revenue And Forecasts to 2027, By Country (%)
FIGURE 38. Germany Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 39. France Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 40. UK Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 41. Asia Pacific Drug delivery systems market revenue Overview, by Country (2018) (us $ mn)
FIGURE 42. Asia Pacific Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 43. Asia Pacific Drug delivery systems market Revenue And Forecasts to 2027, By Country (%)
FIGURE 44. China Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 45. Japan Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 46. India Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 47. Middle East & Africa drug delivery systems market REVENUE, by Country, 2018 (US$ MN)
FIGURE 48. Middle East & Africa Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 49. Middle East & Africa Drug delivery systems market Revenue And Forecasts to 2027, By Country (%)
FIGURE 50. UAE Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 51. Saudi Arabia Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 52. South Africa Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 53. South and Central America drug delivery systems market REVENUE, by Country, 2017 (US$ MN)
FIGURE 54. South and Central America Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 55. South and Central America Drug delivery systems market SHARE BY COUNTRY, 2017 AND 2027 (%)
FIGURE 56. Brazil drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 57. Comparative Company Analysis
FIGURE 58. Growth Strategies done by the companies in the Market, (%)
The List of Companies
- BD (Becton Dickinson & Company)
- Boston Scientific Corporation
- Novo Nordisk A/S
- Bausch Health Companies Inc.
- Baxter International, Inc.
- Boehringer Ingelheim
- Novartis AG
- GlaxoSmithKline plc.
- Johnson & Johnson Services, Inc.
- Terumo Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For